Nautilus Biotechnology (NAUT) Amortizatization of Intangibles (2020 - 2026)

Nautilus Biotechnology's (NAUT) quarterly Amortizatization of Intangibles came in at $1.1 million in Q1 2026, up 111.09% year-on-year from $541000.0 in Q1 2025, and down 72.81% quarter-over-quarter from $4.2 million in Q4 2025.

Nautilus Biotechnology (NAUT) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Nautilus Biotechnology has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $1.1 million for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $1.1 million, up 111.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 46.04% YoY), and the FY2025 annual result was $1.4 million, down 67.57% from the prior year.
  • Amortizatization of Intangibles came in at $1.1 million for Q1 2026 at Nautilus Biotechnology, down from $4.2 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $4.2 million in Q4 2025 to a low of -$1.0 million in Q3 2025.
  • The 5-year median for Amortizatization of Intangibles is $669000.0 (2023), against an average of $933176.5.
  • Across the five-year window, Amortizatization of Intangibles soared 556.52% in 2022 and tumbled 6662.5% in 2025, its largest moves.
  • Nautilus Biotechnology's Amortizatization of Intangibles stood at $1.9 million in 2022, then plunged by 66.7% to $619000.0 in 2023, then surged by 255.74% to $2.2 million in 2024, then soared by 90.74% to $4.2 million in 2025, then sank by 72.81% to $1.1 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $1.1 million (Q1 2026), $4.2 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Nautilus Biotechnology 289.99 Mn 194.12 Mn - 1.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.14 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 4.20 Mn
Dec 31, 2025 4.20 Mn
Sep 30, 2025 -1.05 Mn
Sep 30, 2025 -1.05 Mn
Jun 30, 2025 1.80 Mn
Jun 30, 2025 1.80 Mn
Mar 31, 2025 541,000.00
Mar 31, 2025 541,000.00
Dec 31, 2024 2.20 Mn
Dec 31, 2024 2.20 Mn
Sep 30, 2024 16,000.00
Sep 30, 2024 16,000.00
Jun 30, 2024 1.41 Mn
Jun 30, 2024 1.41 Mn
Mar 31, 2024 751,000.00
Mar 31, 2024 751,000.00
Dec 31, 2023 619,000.00
Dec 31, 2023 619,000.00